Sanofi taps BioClinica for CTMS software; Amgen gets nod for tech in trials;

> Sanofi ($SNY) selected BioClinica's ($BIOC) clinical trial management system (CTMS) called OnPoint. Release

> The Institute of Cancer Research, London, has begun using U.K. software company Dotmatics' data visualization and analytics tool called Vortex for cancer drug R&D. Release

> Biopharma giant Amgen ($AMGN) won kudos for its use of software in managing aspects of clinical trials. Article

> Reuters notes some signs of life in the biotech venture capital scene. Item

> Xconomy's Luke Timmerman lists those in biotech you should follow on Twitter. Column

And Finally… Snake-arm robots offer the next generation of minimally invasive surgical tools. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.